Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Safety Study of Electrocardiogram (ECG) Effects of Sancuso® (Granisetron TDS)

This study has been completed.
Information provided by:
Prostrakan Pharmaceuticals Identifier:
First received: April 29, 2009
Last updated: September 24, 2010
Last verified: October 2009
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: September 2009
  Primary Completion Date: August 2009 (Final data collection date for primary outcome measure)